Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates
NCT02578277
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
CYP and transporter probe substrates
DRUG:
BMS-955176
DRUG:
BMS-955176 plus CYP and transporter probe substrates
Sponsor
ViiV Healthcare